Personalized skin startup CUTISS raises $7 million

26.06.2018 13:10, Robynn Weldon

Skin graft pioneer CUTISS has closed its series A financing round with $7.255 million of investment from Giammaria Giuliani, Yellowstone Holding, Zürcher Kantonalbank and private investors.

This funding success follows closely on CUTISS founder Daniela Marino’s trip to Boston with the Venture Leaders Life Sciences team 2018. “Thanks to Venturelab, I was able to manage a great investor roadshow and expose my business to a new market,” she said.

CUTISS, a spin-off of the University of Zurich (UZH), which develops skin grafts bio-engineered from a patient’s own skin cells for the best recovery from burns or other skin defects, was also one of the five highest-ranked newcomers in the 2017 TOP 100.



Every year, more than 50 million people around the world need surgical intervention to restore skin function. The new investment will be used to scale up production of denovoSkin™ and to develop the next generation of skin grafts.